Levolin Information
Levolin, a prescription drug, is manufactured in various forms such as Respules,Inhaler,Syrup,Tablet,Rotacaps. It is primarily used for the treatment of Asthma. Secondary and off-label uses of Levolin have also been mentioned below.
The right dosage of Levolin depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Some other side effects of Levolin have been listed ahead. Normally, these side effects of Levolin are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Levolin has a Moderate effect for pregnant women and Moderate effect on lactating mothers. It is important to know if Levolin has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Levolin related warnings section.
Other conditions have been mentioned below in the Levolin contraindications section.
Additionally, Levolin may also adversely react with other medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Levolin is considered not safe while driving, and is not addictive.
Levolin Benefits & Uses
Levolin is used to treat the following -
Main Benefits
Other Benefits
Levolin Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Levolin Related Warnings
-
Is the use of Levolin safe for pregnant women?
Levolin can have harmful effects in pregnant women. If you experience any discomfort after using Levolin, then discontinue the use and take your doctor's advice.
Moderate -
Is the use of Levolin safe during breastfeeding?
Levolin can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
Moderate -
What is the effect of Levolin on the Kidneys?
Levolin rarely harms the kidneys.
Mild -
What is the effect of Levolin on the Liver?
Levolin does not damage the liver.
Safe -
What is the effect of Levolin on the Heart?
Levolin has very mild side effects on the heart.
Mild
Severe Interaction of Levolin with Other Drugs
Levolin should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Levolin Contraindications
If you are suffering from any of the following diseases, you should not take Levolin unless your doctor advises you to do so -
- Kidney Disease
- Heart Disease
- Hyperthyroidism
- Thyroid problems
- Diabetes
- Drug Allergy
- Potassium Deficiency
Frequently asked Questions about Levolin
-
Is this Levolin habit forming or addictive?
Levolin does not cause addiction.
No -
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Levolin. So it is best to avoid driving.
Dangerous -
Is it safe?
Yes, but take Levolin only as per medical advice.
Safe, but take only on Doctor's advise -
Is it able to treat mental disorders?
There is no benefit of taking Levolin for mental disorders.
No
Levolin Interactions with Food and Alcohol
-
Interaction between Food and Levolin
It is safe to take Levolin with food.
Safe -
Interaction between Alcohol and Levolin
Consult your doctor before consuming alcohol while taking Levolin as it can have severe side effects.
Severe
See all substitutes for Levolin
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xopenex® (levalbuterol hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 763-765
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xopenex® (levalbuterol hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 763-765
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xopenex® (levalbuterol hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 763-765
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xopenex® (levalbuterol hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 763-765
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xopenex® (levalbuterol hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 763-765
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xopenex® (levalbuterol hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 763-765
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xopenex® (levalbuterol hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 763-765
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xopenex® (levalbuterol hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 763-765
